68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer

Clinical trial NCT03617588 · COMPLETED

Trial details

NCT number: NCT03617588
Sponsor: Theragnostics Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2018-06-18
Primary completion: 2019-06-12
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.